TIM-3 could be expressed on NK cells, dendritic cells, CD8+ T cells, monocytes, and other T-cell subsets to regulate cancer immunity (Miller et al., 2019; Solinas et al., 2019). This evidence concerns the gene HAVCR2 and cancer.